Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Alessandro Casini, Sylvia von Mackensen, Cristina Santoro, Claudia Djambas Khayat, Meriem Belhani, Cecil Ross, Akbar Dorgalaleh, Arshi Naz, Ekrem Ünal, Magy Abdelwahab, Elise Dupuis Lozeron, Nathalie Trillot, Sophie Susen, Flora Peyvandi, Philippe de Moerloose

Blood (2021) 137 (22): 3127–3136.

https://doi.org/10.1182/blood.2020009472

Published: 2021

Includes: Supplemental data

Journal Articles

Fibg 390-396A Limits Metastatic Potential Via a Mechanism Independent of Fibrin-Myeloid Cell Interactions, but Prospectively through the Disruption of FXIII-Mediated Fibrin Crosslinking

Brenton J Francisco, MD, Balkrishan Sharma, PhD, Leah A. Rosenfeldt, BS, Duaa Mureb, BS, Joseph S. Palumbo, MD

Blood (2019) 134 (Supplement_1): 2385.

https://doi.org/10.1182/blood-2019-131644

Published: 2019

Journal Articles

Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-Marketing Observational Study

Bruce A. Schwartz, PhD, Flora Peyvandi, MD PhD, Cristina Solomon, Sigurd Knaub, Balazs Toth

Blood (2019) 134 (Supplement_1): 4971.

https://doi.org/10.1182/blood-2019-129891

Published: 2019

Journal Articles

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Mario von Depka, MD PhD, Katharina Kaiser, Carsten Detering, MSc, Mahnaz Ekhlasi-Hundrieser, PhD, Christiane Pfarrer, DVM, Prof, Stefanie Lehner, DVM, PhD

Blood (2019) 134 (Supplement_1): 4917.

https://doi.org/10.1182/blood-2019-122407

Published: 2019

Journal Articles

Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth

Balkrishan Sharma, PhD, Duaa Mureb, BS, Sumit Murab, PhD, Leah A. Rosenfeldt, BS, Brenton J Francisco, MD, Alexander A Boucher, MD, Rachel Cantrell, BS, Jacob Mast, Matthew J. Flick, PhD, Patrick W Whitlock, MD, Joseph S. Palumbo, MD

Blood (2019) 134 (Supplement_1): 1111.

https://doi.org/10.1182/blood-2019-130497

Published: 2019

Journal Articles

Treatment of rare factor deficiencies other than hemophilia

Marzia Menegatti, Flora Peyvandi

Blood (2019) 133 (5): 415–424.

https://doi.org/10.1182/blood-2018-06-820738

Published: 2019

Journal Articles

Efficacy and Pharmacokinetics of a New Fibrinogen Concentrate in Treating Acute Bleeding in Adolescent Patients with Congenital Fibrinogen Deficiency

Flora Peyvandi, MD PhD, Bruce A. Schwartz, Sigurd Knaub

Blood (2018) 132 (Supplement 1): 2501.

https://doi.org/10.1182/blood-2018-99-116572

Published: 2018

Journal Articles

Fibrinogen Concentrate Vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Ashok Roy, Nigel Sargant, Savita Rangarajan, Sue Alves, John Bell, Sophia Stanford, Cristina Solomon, Irina Kruzhkova, Sigurd Knaub, Faheez Mohamed

Blood (2018) 132 (Supplement 1): 2549.

https://doi.org/10.1182/blood-2018-99-118145

Published: 2018

Journal Articles

Efficacy and Safety of Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency — a Phase 3 Study

Flora Peyvandi, MD PhD, Bruce A. Schwartz, Sigurd Knaub

Blood (2018) 132 (Supplement 1): 2502.

https://doi.org/10.1182/blood-2018-99-116440

Published: 2018

Journal Articles

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

Allison S. Remiker, MD, Leah A. Rosenfeldt, BS, Greg N. Adams, PhD, Matthew J. Flick, PhD, Malinda D. Frederick, BS, Joseph S. Palumbo, MD

Blood (2017) 130 (Supplement 1): 1063.

https://doi.org/10.1182/blood.V130.Suppl_1.1063.1063

Published: 2017

Journal Articles

Efficacy of Human Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and to Prevent Bleeding during and after Surgery in Subjects with Congenital Fibrinogen Deficiency

Bruce A. Schwartz, PhD, Cecil Ross, MD, Bella Madan, MD, Toshko Jelev Lissitchkov, MD, Mehran Karimi, MD, Sigurd Knaub, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 1404.

https://doi.org/10.1182/blood.V128.22.1404.1404

Published: 2016

Journal Articles

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Blood (2016) 128 (22): 207.

https://doi.org/10.1182/blood.V128.22.207.207

Published: 2016

Journal Articles

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Mahdi Shahriari, MD, Mehran Karimi, MD

Blood (2016) 128 (22): 4801.

https://doi.org/10.1182/blood.V128.22.4801.4801

Published: 2016

Journal Articles

Studies on the Genetic Mutations of Hereditary Fibrinogen Disorder

Rong-Fu Zhou, MD, Zhou Na, OuYang Jian

Blood (2016) 128 (22): 4954.

https://doi.org/10.1182/blood.V128.22.4954.4954

Published: 2016

Journal Articles

Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study

Elena Varotto, Giovanna Sanna, Luca Spiezia, Stefania Varotto, MD, Marta Pillon, MD, Laura Sainati, MD, Alessandra Todesco, Barbara Buldini, MD, Maria Grazia Petris, Raffaella Colombatti, Manuela Tumino, Giada Biddeci, Antonio Marzollo, Maria Gabelli, Maria Paola Boaro, Elena Campello, Paolo Simioni, MD PhD, Giuseppe Basso, Prof, MD, Maria Caterina Putti, MD

Blood (2015) 126 (23): 2305.

https://doi.org/10.1182/blood.V126.23.2305.2305

Published: 2015

Journal Articles

Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates in Patients with Congenital Fibrinogen Deficiency: Final Analysis

Cecil Ross, MD, Savita Rangarajan, Mehran Karimi, MD, Bruce A. Schwartz, PhD, Sigurd Knaub, PhD, Flora Peyvandi, MD PhD

Blood (2015) 126 (23): 4680.

https://doi.org/10.1182/blood.V126.23.4680.4680

Published: 2015

Journal Articles

Quality of Life in Children with Rare Bleeding Disorders

Mehran Karimi, MD, Hassan Mohtadi, MD, Sezaneh Haghpanah, MD MPH., Mahboobeh Akbari, BS.

Blood (2015) 126 (23): 4698.

https://doi.org/10.1182/blood.V126.23.4698.4698

Published: 2015

Journal Articles

Autosomal Recessive Inherited Bleeding Disorders in Pakistan, a Cross Sectional Study from Selected Regions

Arshi Naz, MSc.PhD, Mohammad younus Jamal, M.B;B.S, PhD, Samina Tufail Amanat, FCPS, MB, BS, Humayun Patel, MSc., Akbar Agha, M.B;B.S, fazal-E- Razik, Nisar Ahmed, FCPS haematology, Ayisha Imran, M.B;B.S, FCPS haematology, Tahir Shamsi, MBBS, MRCPath,FRCPath

Blood (2015) 126 (23): 4708.

https://doi.org/10.1182/blood.V126.23.4708.4708

Published: 2015

Journal Articles

Identification of Novel Mutations with Molecular Modelling of Missense Mutations of Congenital Afibrinogenemia Patients in Pakistan

Tehmina nafees sonia Khan, M.B;B.S ,PhD, Arshi Naz, MSc.PhD, Arjit Biswas, Anne Goodeve, PhD, Nisar Ahmed, FCPS haematology, Shariq Ahmed, B.S, Tahir Shamsi, MBBS, MRCPath,FRCPath, Johannes Oldenburg

Blood (2015) 126 (23): 4664.

https://doi.org/10.1182/blood.V126.23.4664.4664

Published: 2015

Journal Articles

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Blood (2014) 124 (21): 2838.

https://doi.org/10.1182/blood.V124.21.2838.2838

Published: 2014

NARROW

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Fibg 390-396A Limits Metastatic Potential Via a Mechanism Independent of Fibrin-Myeloid Cell Interactions, but Prospectively through the Disruption of FXIII-Mediated Fibrin Crosslinking

Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-Marketing Observational Study

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth

Treatment of rare factor deficiencies other than hemophilia

Efficacy and Pharmacokinetics of a New Fibrinogen Concentrate in Treating Acute Bleeding in Adolescent Patients with Congenital Fibrinogen Deficiency

Fibrinogen Concentrate Vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Efficacy and Safety of Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency — a Phase 3 Study

Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis

Efficacy of Human Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and to Prevent Bleeding during and after Surgery in Subjects with Congenital Fibrinogen Deficiency

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders?

Studies on the Genetic Mutations of Hereditary Fibrinogen Disorder

Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study

Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates in Patients with Congenital Fibrinogen Deficiency: Final Analysis

Quality of Life in Children with Rare Bleeding Disorders

Autosomal Recessive Inherited Bleeding Disorders in Pakistan, a Cross Sectional Study from Selected Regions

Identification of Novel Mutations with Molecular Modelling of Missense Mutations of Congenital Afibrinogenemia Patients in Pakistan

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only